Surgical complications and technical failure of simultaneous pancreas-kidney transplantation: A 22-year experience from a single center.
Bruno Fraga DiasRoberto Calças MarquesCatarina Isabel RibeiroVitória FariaPatrícia DominguesCatarina RibeiroJosé SilvanoDonzília SilvaSofia PedrosoManuela AlmeidaJorge MalheiroLa Salete MartinsPublished in: Clinical transplantation (2024)
Simultaneous pancreas-kidney transplantation (SPKT) is the best treatment for selected individuals with type 1 diabetes mellitus and end-stage renal disease. Despite advances in surgical techniques, donor and recipient selection, and immunosuppressive therapies, SPKT remains a complex procedure with associated surgical complications and adverse consequences. We conducted a retrospective study that included 263 SPKT procedures performed between May 2000, and December 2022. A total of 65 patients (25%) required at least one relaparotomy, resulting in an all-cause relaparotomy rate of 2.04 events per 100 in-hospital days. Lower donor body mass index was identified as an independent factor associated with reoperation (OR .815; 95% CI: .725-.917, p = .001). Technical failure (TF) occurred in 9.9% of cases, primarily attributed to pancreas graft thrombosis, intra-abdominal infections, bleeding, and anastomotic leaks. Independent predictors of TF at 90 days included donor age above 36 years (HR 2.513; 95% CI 1.162-5.434), previous peritoneal dialysis (HR 2.503; 95% CI 1.149-5.451), and specific pancreas graft reinterventions. The findings highlight the importance of carefully considering donor and recipient factors in SPKT. The incidence of TF in our study population aligns with the recent series. Continuous efforts should focus on identifying and mitigating potential risk factors to enhance SPKT outcomes, thereby reducing post-transplant complications.
Keyphrases
- end stage renal disease
- peritoneal dialysis
- kidney transplantation
- risk factors
- chronic kidney disease
- body mass index
- healthcare
- pulmonary embolism
- physical activity
- rectal cancer
- atrial fibrillation
- ejection fraction
- type diabetes
- metabolic syndrome
- minimally invasive
- insulin resistance
- risk assessment
- combination therapy
- acute care